Wiley Bros. Aintree Capital, LLC Insulet Corp Transaction History
Wiley Bros. Aintree Capital, LLC
- $5.07 Billion
- Q3 2024
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Insulet Corp stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 902 shares of PODD stock, worth $246,669. This represents 0.0% of its overall portfolio holdings.
Number of Shares
902Holding current value
$246,669% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PODD
# of Institutions
687Shares Held
62.7MCall Options Held
640KPut Options Held
881K-
Vanguard Group Inc Valley Forge, PA8.47MShares$2.32 Billion0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.77MShares$2.13 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$1.66 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.91MShares$797 Million0.03% of portfolio
-
Baillie Gifford & CO2.28MShares$622 Million0.4% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $19B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...